Warrants - Schedule of Outstanding and Exercisable Warrants (Details) - Warrant [Member] |
3 Months Ended |
---|---|
Mar. 31, 2025
$ / shares
shares
| |
Schedule of Outstanding and Exercisable Warrants [Line Items] | |
Warrants Outstanding, Number of Shares | shares | 3,016,635 |
Warrants Outstanding, Weighted Average Remaining Contractual life (in years) | 9 months 18 days |
Warrants Outstanding, Weighted Average Exercise Price | $ / shares | $ 6.6907 |
Warrants Exercisable, Number of Shares | shares | 3,016,635 |
Warrants Exercisable, Weighted Average Exercise Price | $ / shares | $ 6.6907 |
X | ||||||||||
- Definition Warrants exercisable, number of shares. No definition available.
|
X | ||||||||||
- Definition Warrants exercisable, weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Warrants outstanding, weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|